Immunic
IMUX
₹77.46
Share price
1.83%
Change (1 day)
-33.62%
Change (1 year)
Categories
Earnings for Immunic (IMUX)
Earnings in 2024 (TTM): -₹8.25 Billion
According to Immunic's latest financial reports the company's current earnings are N/A. , an increase over its 2023 earnings that were of -₹8.54 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Immunic from 2013 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | -₹8.44 Billion | -1.18% |
| 2023 | -₹8.54 Billion | 14.68% |
| 2022 | -₹7.45 Billion | -5.62% |
| 2021 | -₹7.89 Billion | 87.18% |
| 2020 | -₹4.22 Billion | 32.24% |
| 2019 | -₹3.19 Billion | -9.25% |
| 2018 | -₹3.52 Billion | -22.5% |
| 2017 | -₹4.54 Billion | 27.6% |
| 2016 | -₹3.56 Billion | -20.82% |
| 2015 | -₹4.49 Billion | 9.34% |
| 2014 | -₹4.11 Billion | 33.05% |
| 2013 | -₹3.09 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -₹12.3 Billion | 45.73% | 🇺🇸 USA |